Literature DB >> 25306965

Palmitoylation as a key factor to modulate SP-C-lipid interactions in lung surfactant membrane multilayers.

Nuria Roldan1, Erik Goormaghtigh2, Jesús Pérez-Gil1, Begoña Garcia-Alvarez3.   

Abstract

Surfactant protein C (SP-C) has been regarded as the most specific protein linked to development of mammalian lungs, and great efforts have been done to understand its structure-function relationships. Previous evidence has outlined the importance of SP-C palmitoylation to sustain the proper dynamics of lung surfactant, but the mechanism by which this posttranslational modification aids SP-C to stabilize the interfacial surfactant film along the compression-expansion breathing cycles, is still unrevealed. In this work we have compared the structure, orientation and lipid-protein interactions of a native palmitoylated SP-C with those of a non-palmitoylated recombinant SP-C (rSP-C) form in air-exposed multilayer membrane environments, by means of ATR-FTIR spectroscopy. Palmitoylation does not affect the secondary structure of the protein, which exhibits a full α-helical conformation in partly dehydrated phospholipid multilayer films. However, differences between the Amide I band of the IR spectrum of palmitoylated and non-palmitoylated proteins suggest subtle differences affecting the environment of their helical component. These differences are accompanied by differential effects on the IR bands from phospholipid phosphates, indicating that palmitoylation modulates lipid-protein interactions at the headgroup region of phospholipid layers. On the other hand, the relative dichroic absorption of polarized IR has allowed calculating that the palmitoylated protein adopts a more tilted transmembrane orientation than the non-palmitoylated SP-C, likely contributing to more compact, dehydrated and possibly stable multilayer lipid-protein films. As a whole, the behavior of multilayer films containing palmitoylated SP-C may reflect favorable structural properties for surfactant reservoirs at the air-liquid respiratory interface.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATR-FTIR; Lung surfactant; Palmitoylation; Protein–lipid interaction; SP-C

Mesh:

Substances:

Year:  2014        PMID: 25306965     DOI: 10.1016/j.bbamem.2014.10.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface Activity.

Authors:  Alejandro Cerrada; Thomas Haller; Antonio Cruz; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2015-12-01       Impact factor: 4.033

2.  Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.

Authors:  Nuria Roldan; Thomas K M Nyholm; J Peter Slotte; Jesús Pérez-Gil; Begoña García-Álvarez
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

3.  GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.

Authors:  Qianqian Pang; Chunyi Liu; Yulong Qiao; Jian Zhao; Sin Man Lam; Mei Mei; Guanghou Shui; Shilai Bao; Qiuling Li
Journal:  Sci China Life Sci       Date:  2021-03-16       Impact factor: 6.038

Review 4.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 5.  Pulmonary surfactant as a versatile biomaterial to fight COVID-19.

Authors:  Lore Herman; Stefaan C De Smedt; Koen Raemdonck
Journal:  J Control Release       Date:  2021-11-20       Impact factor: 9.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.